Roszdravnadzor-2021-0099-V499
Type II variation for application Roszdravnadzor-2021-0099. Type II variation: Labeling Change for Brextanib — critical change
Variation Number
Roszdravnadzor-2021-0099-V499
Type
Type II
Application
Change
Status
Submitted
Fee
€65,408
Submitted
2023-07-31
Approved
—
Description
Type II variation: Labeling Change for Brextanib — critical change